BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31399477)

  • 1. Calcium Channel Blockers and Risk of Lymphedema among Breast Cancer Patients: Nested Case-Control Study.
    Stolarz AJ; Lakkad M; Klimberg VS; Painter JT
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1809-1815. PubMed ID: 31399477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium Channel Blockers and the Risk for Lung Cancer: A Population-Based Nested Case-Control Study.
    Rotshild V; Azoulay L; Feldhamer I; Perlman A; Glazer M; Muszkat M; Matok I
    Ann Pharmacother; 2019 May; 53(5):445-452. PubMed ID: 30442036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Association Between Calcium Channel Blocker Use and Breast Cancer Recurrence in Postsurgical Women: A Population-Based Case-Control Study in Taiwan.
    Shih JH; Kao LT; Chung CH; Liao GS; Fann LY; Chien WC; Li IH
    J Clin Pharmacol; 2020 Jun; 60(6):785-792. PubMed ID: 32020656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between calcium channel blockers and breast cancer: a meta-analysis of observational studies.
    Chen Q; Zhang Q; Zhong F; Guo S; Jin Z; Shi W; Chen C; He J
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):711-8. PubMed ID: 24829113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control Study.
    Rotshild V; Azoulay L; Feldhamer I; Perlman A; Muszkat M; Matok I
    Pharmacotherapy; 2019 Jun; 39(6):690-696. PubMed ID: 30917404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly.
    Bettiol A; Lucenteforte E; Vannacci A; Lombardi N; Onder G; Agabiti N; Vitale C; Trifirò G; Corrao G; Roberto G; Mugelli A; Chinellato A;
    Clin Drug Investig; 2017 Dec; 37(12):1165-1174. PubMed ID: 28975522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
    Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
    Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).
    Grimaldi-Bensouda L; Klungel O; Kurz X; de Groot MC; Maciel Afonso AS; de Bruin ML; Reynolds R; Rossignol M
    BMJ Open; 2016 Jan; 6(1):e009147. PubMed ID: 26747033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
    Meier CR; Derby LE; Jick SS; Jick H
    Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
    Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
    JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate Control With Beta-blockers Versus Calcium Channel Blockers in the Emergency Setting: Predictors of Medication Class Choice and Associated Hospitalization.
    Atzema CL; Austin PC
    Acad Emerg Med; 2017 Nov; 24(11):1334-1348. PubMed ID: 28853232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
    Gómez-Acebo I; Dierssen-Sotos T; Palazuelos C; Pérez-Gómez B; Lope V; Tusquets I; Alonso MH; Moreno V; Amiano P; Molina de la Torre AJ; Barricarte A; Tardon A; Camacho A; Peiro-Perez R; Marcos-Gragera R; Muñoz M; Michelena-Echeveste MJ; Ortega Valin L; Guevara M; Castaño-Vinyals G; Aragonés N; Kogevinas M; Pollán M; Llorca J
    PLoS One; 2016; 11(8):e0159672. PubMed ID: 27508297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Calcium Channel Blockers and Breast Cancer Risk in the Women's Health Initiative.
    Brasky TM; Krok-Schoen JL; Liu J; Chlebowski RT; Freudenheim JL; Lavasani S; Margolis KL; Qi L; Reding KW; Shields PG; Simon MS; Wactawski-Wende J; Wang A; Womack C; Manson JE
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1345-1348. PubMed ID: 28765339
    [No Abstract]   [Full Text] [Related]  

  • 14. The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.
    Rotshild V; Azoulay L; Zarifeh M; Masarwa R; Hirsh-Raccah B; Perlman A; Muszkat M; Matok I
    Drug Saf; 2018 Jun; 41(6):555-564. PubMed ID: 29484611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
    J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers and the incidence of breast and prostate cancer: A meta-analysis.
    Thakur AA; Wang X; Garcia-Betancourt MM; Forse RA
    J Clin Pharm Ther; 2018 Aug; 43(4):519-529. PubMed ID: 29656432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
    Holmes S; Griffith EJ; Musto G; Minuk GY
    Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of concomitant treatment with a CYP3A4 inhibitor and a calcium channel blocker.
    Yoshida M; Matsumoto T; Suzuki T; Kitamura S; Mayama T
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):70-5. PubMed ID: 17918187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Stahl M; Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Webster J
    J Hum Hypertens; 2000 May; 14(5):299-304. PubMed ID: 10822315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphedema following taxane-based chemotherapy in women with early breast cancer.
    Lee MJ; Beith J; Ward L; Kilbreath S
    Lymphat Res Biol; 2014 Dec; 12(4):282-8. PubMed ID: 25411764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.